Cargando…
Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review
Diet plays a crucial role in homeostasis maintenance. Plants and spices containing flavonoids have been widely used in traditional medicine for thousands of years. Flavonols present in our diet may prevent cancer initiation, promotion and progression by modulating important enzymes and receptors in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268460/ https://www.ncbi.nlm.nih.gov/pubmed/35807785 http://dx.doi.org/10.3390/nu14132604 |
_version_ | 1784743988369031168 |
---|---|
author | Kubina, Robert Krzykawski, Kamil Kabała-Dzik, Agata Wojtyczka, Robert D. Chodurek, Ewa Dziedzic, Arkadiusz |
author_facet | Kubina, Robert Krzykawski, Kamil Kabała-Dzik, Agata Wojtyczka, Robert D. Chodurek, Ewa Dziedzic, Arkadiusz |
author_sort | Kubina, Robert |
collection | PubMed |
description | Diet plays a crucial role in homeostasis maintenance. Plants and spices containing flavonoids have been widely used in traditional medicine for thousands of years. Flavonols present in our diet may prevent cancer initiation, promotion and progression by modulating important enzymes and receptors in signal transduction pathways related to proliferation, differentiation, apoptosis, inflammation, angiogenesis, metastasis and reversal of multidrug resistance. The anticancer activity of fisetin has been widely documented in numerous in vitro and in vivo studies. This review summarizes the worldwide, evidence-based research on the activity of fisetin toward various types of cancerous conditions, while describing the chemopreventive and therapeutic effects, molecular targets and mechanisms that contribute to the observed anticancer activity of fisetin. In addition, this review synthesized the results from preclinical studies on the use of fisetin as an anticancer agent. Based on the available literature, it might be suggested that fisetin has a bioactive potential to become a complementary drug in the prevention and treatment of cancerous conditions. However, more in-depth research is required to validate current data, so that this compound or its derivatives can enter the clinical trial phase. |
format | Online Article Text |
id | pubmed-9268460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92684602022-07-09 Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review Kubina, Robert Krzykawski, Kamil Kabała-Dzik, Agata Wojtyczka, Robert D. Chodurek, Ewa Dziedzic, Arkadiusz Nutrients Review Diet plays a crucial role in homeostasis maintenance. Plants and spices containing flavonoids have been widely used in traditional medicine for thousands of years. Flavonols present in our diet may prevent cancer initiation, promotion and progression by modulating important enzymes and receptors in signal transduction pathways related to proliferation, differentiation, apoptosis, inflammation, angiogenesis, metastasis and reversal of multidrug resistance. The anticancer activity of fisetin has been widely documented in numerous in vitro and in vivo studies. This review summarizes the worldwide, evidence-based research on the activity of fisetin toward various types of cancerous conditions, while describing the chemopreventive and therapeutic effects, molecular targets and mechanisms that contribute to the observed anticancer activity of fisetin. In addition, this review synthesized the results from preclinical studies on the use of fisetin as an anticancer agent. Based on the available literature, it might be suggested that fisetin has a bioactive potential to become a complementary drug in the prevention and treatment of cancerous conditions. However, more in-depth research is required to validate current data, so that this compound or its derivatives can enter the clinical trial phase. MDPI 2022-06-23 /pmc/articles/PMC9268460/ /pubmed/35807785 http://dx.doi.org/10.3390/nu14132604 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kubina, Robert Krzykawski, Kamil Kabała-Dzik, Agata Wojtyczka, Robert D. Chodurek, Ewa Dziedzic, Arkadiusz Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title_full | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title_fullStr | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title_full_unstemmed | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title_short | Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review |
title_sort | fisetin, a potent anticancer flavonol exhibiting cytotoxic activity against neoplastic malignant cells and cancerous conditions: a scoping, comprehensive review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268460/ https://www.ncbi.nlm.nih.gov/pubmed/35807785 http://dx.doi.org/10.3390/nu14132604 |
work_keys_str_mv | AT kubinarobert fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview AT krzykawskikamil fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview AT kabaładzikagata fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview AT wojtyczkarobertd fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview AT chodurekewa fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview AT dziedzicarkadiusz fisetinapotentanticancerflavonolexhibitingcytotoxicactivityagainstneoplasticmalignantcellsandcancerousconditionsascopingcomprehensivereview |